Crossmark

Neoadjuvant PD-(L)1 blockade with or without chemotherapy versus chemotherapy alone in mismatch repair-deficient, potentially resectable stage III-IVA gastric cancer patients: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1186/s12957-024-03601-4

Published Online: 2024-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xuchen

Wang, Huiyun

Li, Yi

Yan, Weihua

Chen, Yunqing

Song, Shanai

Liu, Ning

Zhang, Chuantao

Niu, Zhaojian

Hou, Helei
Funding

Funding for this research was provided by:

Natural Science Foundation of Shandong Province (ZR2020MH225)

Medical Foundation of Wu Jieping (320.6750.2020-02-44)

Special Funding for Qilu Sanitation and Health Leading Talents Cultivation Project
License Information

Text and Data Mining valid from 2024-11-26

Version of Record valid from 2024-11-26
More Information

Article History

Received: 5 August 2024

Accepted: 19 November 2024

First Online: 26 November 2024

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the Affiliated Hospital of Qingdao University (Approval No. QYFYWZLL27969, Qingdao, China). All the enrolled patients have read and signed the informed consents.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below